Cabozantinib - Small Molecule (ID:10194-106)
HMS LINCS ID: | 10194-106 |
Name: | Cabozantinib |
Alternative Names: | XL-184; BMS-907351 |
LINCS ID: | LSM-1195 |
PubChem CID: | 25102847 |
ChEBI ID: | |
ChEMBL ID: | |
Molecular Mass: | 501.17 |
InChi: | InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34) |
InChi Key: | ONIQOQHATWINJY-UHFFFAOYSA-N |
SMILES: | COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F |
Relevant Citations: | |
Comments: | |
Date Publicly Available: | |
Most Recent Update: | 2016-04-04 |
Target Affinity:
(see Study 20000)Target Affinity Spectrum Value | HUGO Gene Name |
---|---|
KDR, KIT, MET, RET | |
2 (equivalent to 100 nM ≤ Kd < 1µM) | AXL, FLT1, FLT3, FLT4, MERTK, NTRK2, ROS1, TEK, TYRO3 |
Datasets:
HMS Dataset ID | Dataset Title | HMS Dataset Type |
---|---|---|
20000 | Target Affinity Spectrum (TAS) vectors for compounds in the HMS LINCS small molecule library. | Analysis |
20343 | Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values | Microscopy/Imaging |
20344 | Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics | Analysis |
Batch Information:
HMS LINCS Batch ID | Provider | Provider Batch ID |
---|---|---|
10194-106-1 | Haoyuan chemexpress | HY-12044-20110919 |
10194-106-2 | MedChem Express | 09581 |
(Kd <100 nM)